Patent details

EP2621496 Title: CRYSTALLINE NALOXOL-PEG CONJUGATE

Basic Information

Publication number:
EP2621496
PCT Application Number:
SE2011051161
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP118296862
PCT Publication Number:
WO2012044243
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CRYSTALLINE NALOXOL-PEG CONJUGATE
French Title of Invention:
CONJUGUÉ CRISTALLIN DE NALOXOL-PEG
German Title of Invention:
KRISTALLINES NALOXOL-PEG-KONJUGAT
SPC Number:

Dates

Filing date:
29/09/2011
Grant date:
16/12/2015
EP Publication Date:
07/08/2013
PCT Publication Date:
05/04/2012
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/08/2013
EP B1 Publication Date:
16/12/2015
EP B2 Publication Date:
12/12/2018
EP B3 Publication Date:
Lapsed date:
Expiration date:
29/09/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/06/2025
 
 

Name:
GRÜNENTHAL GMBH
Address:
Zieglerstraße 6, 52078, Aachen, Germany (DE)

From:
05/12/2018
 
 

Name:
Nektar Therapeutics
Address:
455 Mission Bay Boulevard South, Suite 100, San Francisco, CA 94185, United States (US)

History of Owners

From:
05/12/2018
To:
17/06/2025

Name:
AstraZeneca AB
Address:
Forskargatan 18, 151 85 Södertälje, Sweden (SE)

Agent

Name:
ARONOVA S.A.
From:
24/12/2015
Address:
PO Box 327, 4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
JENSEN, David Richard
Address:
United States (US)

2

Name:
YMÉN, Bo Ingvar
Address:
Sweden (SE)

3

Name:
LECHUGA-BALLESTEROS, David
Address:
United States (US)

4

Name:
BOHLIN, Martin Hans
Address:
Sweden (SE)

5

Name:
PARENT, Stephan
Address:
United States (US)

6

Name:
AURELL, Carl-Johan
Address:
Sweden (SE)

7

Name:
JONAITIS, David Thomas
Address:
United States (US)

8

Name:
ÅSLUND, Bengt Leonard
Address:
Sweden (SE)

9

Name:
SEBHATU, Tesfai
Address:
Sweden (SE)

10

Name:
HEALY, Eric Thomas
Address:
United States (US)

Priority

Priority Number:
388501 P
Priority Date:
30/09/2010
Priority Country:
United States (US)

Classification

IPC classification:
A61K 47/48; A61P 39/00; C07D 489/04;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2025/08
Publication date:
03/07/2025
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

1

Issue number:
201850
Publication date:
12/12/2018
Description:
Patent maintained (B2 publication)

2

Issue number:
201907
Publication date:
13/02/2019
Description:
International Patent Classification Changed

3

Issue number:
202228
Publication date:
13/07/2022
Description:
Inventor(s) changed

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20250000201A
Date Registered:
17/06/2025
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
MARKS & CLERK LLP
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

1

Name:
Nektar Therapeutics
Address:
455 Mission Bay Boulevard South, Suite 100, San Francisco, CA 94185, United States (US)

2

Name:
GRÜNENTHAL GMBH
Address:
Zieglerstraße 6, 52078, Aachen, Germany (DE)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
30/09/2025
Annual Fee Number:
15
Annual Fee Amount:
213 Euro
Expected Payer:
Last Annual Fee Payment Date:
13/09/2024
Last Annual Fee Paid Number:
14
Last Annual Fee Paid Amount:
198 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
17/06/2025 Request For Change 5
18/06/2025 Outgoing Correspondence 1